Study Summary
This trial will use data from past patients and from those who agree to participate over the next 12 months to study the effects of a 4-liter dose of PEG 3350 on patients with hemorrhaging.
- Diverticulosis Bleeding
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 5 years of data will be collected
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Retrospective Cohort
1 of 2
Prospective Cohort
1 of 2
Active Control
Experimental Treatment
415 Total Participants · 2 Treatment Groups
Primary Treatment: Early bowel preparation for colonoscopy · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Texas | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Frequently Asked Questions
Are participants still being sought to join this experiment?
"Affirmative, clinicaltrials.gov data confirms that this medical trial is in the midst of recruitment and was first made public on May 6th 2020. It requires 415 participants to be recruited from one site before it can proceed further." - Anonymous Online Contributor
To what extent is this experiment engaging participants?
"That is correct. According to the information on clinicaltrials.gov, this medical trial was first posted in May of 2020 and remains open for recruitment with a target of 415 participants from one location." - Anonymous Online Contributor